DoW Neurofibromatosis Research Academy - Scholar Award

The Neurofibromatosis Research Academy – Scholar Award is offered by the U.S. Department of Defense through the Defense Health Agency Contracting Activity as part of the Congressionally Directed Medical Research Programs. This funding opportunity is embedded within the Neurofibromatosis Research Program, which is dedicated to advancing scientific knowledge and treatment approaches for neurofibromatosis disorders. These disorders are complex genetic conditions that can result in tumor formation and other systemic complications, and the program aims to foster innovative, high-impact research that can accelerate clinical translation and improve patient outcomes. The primary purpose of the Scholar Award is to support early-career independent investigators who are within ten years of completing their terminal degree. The program is structured to not only fund a defined research project but also to integrate recipients into the Neurofibromatosis Research Academy, a collaborative environment led by a Director and Deputy Director. Scholars are expected to pursue projects that align with at least one of the fiscal year’s Areas of Emphasis, which may include basic science, translational research, or clinical investigation. The award emphasizes both scientific innovation and professional development, aiming to cultivate the next generation of leaders in neurofibromatosis research. Funding under this opportunity supports research-related expenses necessary to execute the proposed project. While specific cost categories are not detailed in the summary, typical allowable costs under Department of Defense research grants include personnel, supplies, equipment, and other direct research expenses, subject to federal grant regulations. There is no cost-sharing or matching requirement for this opportunity, which lowers the financial barrier for applicants and allows institutions to fully leverage federal support. The total program funding is estimated at 3.6 million dollars, with approximately three awards anticipated, indicating a competitive selection process. Eligibility for the award is broad in terms of institutional participation, as the opportunity is described as unrestricted and open to a wide range of entity types, subject to further clarification in the full announcement. However, the individual Principal Investigator, designated as the Scholar, must meet specific career-stage requirements, notably being within ten years of their terminal degree completion, excluding certain professional or personal leave periods. Additionally, each Scholar must designate a Career Guide who provides mentorship and guidance throughout the award period. This Career Guide may be from a different institution, though a secondary guide must be identified if institutional separation exists. The application process requires submission through established federal grant systems and includes standard components such as a research proposal aligned with program priorities. Applicants must ensure compliance with all submission requirements and timelines. The opportunity was posted on June 25, 2026, and applications are due by September 22, 2026. While no pre-application or letter of intent requirement is specified in the available summary, applicants are expected to adhere strictly to submission guidelines and deadlines as outlined in the full funding announcement. Evaluation of applications is expected to focus on scientific merit, alignment with program priorities, and the potential impact of the proposed research, as well as the qualifications of the applicant and the strength of the mentorship plan. The collaborative nature of the academy suggests that reviewers may also consider the applicant’s ability to contribute to and benefit from a structured research network. Successful applicants will join a cohort of scholars and engage in both research and career development activities over the performance period, though the exact duration is not specified in the summary. For questions or technical assistance, applicants may contact the eBRAP Help Desk via phone or email. This centralized support resource assists with accessing application materials and resolving submission issues. Overall, the Neurofibromatosis Research Academy – Scholar Award represents a strategic investment in both scientific advancement and workforce development within a specialized area of biomedical research, combining funding support with structured mentorship and collaborative engagement.

Ensure strong alignment with Neurofibromatosis Research Program priorities and demonstrate a clear mentorship plan through the Career Guide relationship